Dr. Vivekananda Pattabiraman, MD

Dr. Pattabiraman practices at Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital.

Dr. Pattabiraman's NPI, 1467649830, was assigned on October 1, 2007. Dr. Pattabiraman holds Georgia license 065602.

Dr. Pattabiraman's primary practice is Northside Hospital Atlanta, at 1000 Johnson Ferry Road, NE, Atlanta, GA 30342 in Fulton County. The practice phone is (404) 851-8000.

Dr. Pattabiraman's primary practice is Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital. The medical group on file is Emory Healthcare. Dmand AI also links Dr. Pattabiraman to 6 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pattabiraman practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Pattabiraman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Pattabiraman's licenses on file in 4 states: Georgia, Alabama, Kansas and Tennessee.

CMS data shows 279 Medicare services from Dr. Pattabiraman across 4 procedure codes in 2024, for 267 Medicare patients. Medicare paid $25,276 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 267 Medicare patients who saw Dr. Pattabiraman in 2024. The largest group is 75 to 84, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pattabiraman's median patient age at 70, with 58% women.

In 2024, Dr. Pattabiraman wrote 18 Medicare Part D claims for 11 patients. 78% of them were for generic drugs. They cover 10 drugs, with $17,396 in total drug cost. In 2020, CMS named 226 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Pattabiraman for performance year 2024, reported as part of a group. Dr. Pattabiraman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 17 general payments to Dr. Pattabiraman from 7 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $69.